George Magrath Ocuphire Pharma, Inc. (OCUP) insider trading activity

George Magrath is Chief Executive Officer of Ocuphire Pharma, Inc.. Currently has a direct ownership of 599,150 shares of OCUP, which is worth approximately $587,167. The most recent transaction as insider was on Dec 26, 2024, when has been sold 100,000 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $98,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 599K

39.34% 3M change

49.79% 12M change

Total Value Held $587,167

George Magrath Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2024	BUY Open market or private purchase	$98,000 $0.98 p/Share	100,000 Added 14.3%	599,150 Common Stock
Dec 23 2024	BUY Grant, award, or other acquisition	-	6,200 Added 1.23%	499,150 Common Stock
Nov 18 2024	BUY Open market or private purchase	$9,900 $1.02 p/Share	9,706 Added 1.93%	492,950 Common Stock
Nov 15 2024	BUY Open market or private purchase	$91,196 $1.01 p/Share	90,294 Added 15.74%	483,244 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$43,719 $1.18 p/Share	37,050 Reduced 8.62%	392,950 Common Stock
May 17 2024	BUY Open market or private purchase	$8,750 $1.75 p/Share	5,000 Added 1.15%	430,000 Common Stock
Mar 18 2024	BUY Open market or private purchase	$49,000 $1.96 p/Share	25,000 Added 5.56%	425,000 Common Stock
Nov 01 2023	BUY Grant, award, or other acquisition	-	400,000 Added 50.0%	400,000 Common Stock

George Magrath

Chief Executive Officer

Farmington Hills, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Value

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP

Account